Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 25-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 29)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-May-13 New Constructs, LLC N/A HALO: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
24-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - HALONIX LIMITED (HALONIX-IN) 9 $25 View Abstract
24-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
24-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Halozyme Therapeutics, Inc. 40 $460 View Abstract
24-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of HALOZYME THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
24-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: FOLD , CNDO , HALO , OPTR , OREX , GEVA , VNDA -- DRUGS 3 $34.50 View Abstract
23-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for HALO 11 $126.50 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala HALOZYME THERAPEUTICS INC (HALO) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 Reuters Investment Profile N/A Halonix Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
Next 19

Independent Reports (Showing 1 to 10 of 29)

Release
Date Contributor Author Title Pages Price More Info
24-May-13 New Constructs, LLC N/A HALO: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
24-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - HALONIX LIMITED (HALONIX-IN) 9 $25 View Abstract
24-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
24-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Halozyme Therapeutics, Inc. 40 $460 View Abstract
24-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of HALOZYME THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
24-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: FOLD , CNDO , HALO , OPTR , OREX , GEVA , VNDA -- DRUGS 3 $34.50 View Abstract
23-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for HALO 11 $126.50 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala HALOZYME THERAPEUTICS INC (HALO) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 Reuters Investment Profile N/A Halonix Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
Next 19

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.